Swiss pharmaceuticals powerhouse Roche announced Monday it plans to invest $50 billion in the United States over the next ...

Roche has pledged to build a giant weight-loss drug factory in the US as part of a $50bn (£37bn) pledge aimed at heading off ...

Roche has said it will spend $50bn on manufacturing and research and development in the US, becoming the latest pharmaceutical company to promise greater investment in the face of potential tariffs on ...

Trump's looming tariff threats have prompted several announcements, even as the EU pleads for more investment in Europe.

Swiss pharmaceutical giant Roche plans to invest $50 billion in the U.S. over the next five years, the latest major spending commitment by a big drugmaker as the industry faces President Trump's ...

Swiss pharmaceutical giant Roche unveiled ambitious plans on Tuesday for a substantial $50 billion investment in the United States over the coming five years.

Novartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2025 results on April 29, 2025. The Zacks ...

The announcement comes as drugmakers unveil investments to deal with tariffs from the Trump administration, which is seeking to boost domestic manufacturing ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Akums Drugs & Pharmaceuticals Ltd., incorporated in the year 2004, is a company (having a market cap of Rs 7,654.86 Crore) operating in Pharmaceuticals sector. Akums Drugs & Pharmaceuticals Ltd. key ...

Bonus Sep 11, 2018 Sep 13, 2018 Jul 24, 2018 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Jan 02, 1995 Jan 24, 1995 Sep 28, 1995 Bonus Ratio: 1 share(s) for every 1 shares held Rights May 21, ...